Medprin Academy
SBNS 2025 Briefing Part 2 - Neodura™ in Paediatric duroplasty
2025.10.13

1.Meeting Information


On 26 September 2025, Day 3 of SBNS 2025 at Ashton Gate Stadium, Bristol, the 08:30 industry breakfast sponsored by Severn Healthcare focused on “Medprin Dural Patches — the UK experience.” 


The session was chaired by Nigel Mendoza and Sam Hattige. Two speakers shared UK data and experience: Kevin O’Neil (Imperial College Healthcare NHS Trust & Cleveland Clinic London) presented “10 Years’ Experience with ReDura,” followed by William Singleton (Bristol Royal Hospital for Children & UHBW) on paediatric duroplasty (reported separately).


未命名.jpg 

In Part I, Kevin O’Neil distilled a decade of UK practice into a closure logic that is suturable, watertight, low-adhesion and revision-friendly—elevating the patch from a “product choice” to a “pressure-aware, corridor-specific” strategy. Building directly on that foundation, William Singleton moved into paediatrics, where smaller anatomy, fragile tissue and tighter CSF margins demand that material properties be embedded in a pathway of care to achieve reproducible outcomes.

 

图片1.png


2.Utility of Neodura duroplasty in paediatric neurosurgical practice 

Paediatric duroplasty is rarely solved by a “patch-only optimum.” The centre of gravity shifts to a pathway where CSF control, closure tactics and child-specific physiology co-determine outcomes. Singleton’s thesis and cases illuminate this pathway-centric view. 


图片2.png


A.Core message


The problem and the solution: Children frequently present CSF circulation issues and gravity-related risks, while native tissue is limited. Plan for watertight closure from the outset, use native tissue without tension whenever feasible, divert/control CSF, and manage posture/gravity for a period post-op. No substitute can overcome persistent CSF under pressure behind the repair—closure must be designed together with CSF management. 


Why NeoDura: Singleton reported experience with NeoDura™ (a PLLA–porcine gelatin composite). With the same synthetic backbone as ReDura, the gelatin component confers more flexibility and “dura-like” suturability, being thin, tear-resistant, non-swelling on rehydration, and usable for both inlay/underlay sutured repair and onlay cover, simplifying logistics. 


Microstructure and integration: Slides illustrated an ECM-mimicking architecture, aiming for rapid regeneration and reduced foreign-body sensation. 


B.Cases


Case A | Large posterior fossa defect after tumour surgery: Dura cut and sutured + Sealant

To achieve exposure, a sizeable dural loss was inevitable. A template was fashioned; continuous suturing pursued watertightness; CSF diversion strategy implemented. To mitigate “occult ooze,” Singleton used a belt-and-braces approach: sutured repair plus onlay cover and selective sealant, which reduced posterior-fossa CSF leaks in his series. The lesson: control CSF first, then close. 


未命名1.jpg


Case B | Multiple pinholes after midline callosotomy: Dura onlay

With bridging/jural veins in the field, point-by-point suturing can threaten venous injury. ingleton prefers an onlay to create a watertight barrier without passing needles near a large draining vein; follow-up showed stable closure.


图片8.png 

Case C | Lipomyelomeningocele/myelomeningocele reconstruction (recent case without pictures readily available):

In dysraphic spines, reconstruction trumps resection in complexity. Where fascia is limited and mobile scars confound closure, a thin, suturable, non-swelling patch rapidly reconstitutes the barrier, helping reduce persistent leaks and shunt dependence. 


C.“Perfect repair” according to the surgeon 

  • “The perfect dura is dura”: use native dura whenever possible; when not, a substitute should offer suturable handling, integration, and reliable availability.

  • One material for both inlay and onlay streamlines practice and team consistency.

  • Availability matters: long-term access to the same product enables a repeatable learning curve and unit pathway.

 

3.Post-talk discussion highlights

The discussion anchored the pathway view in real-world breadth, clarifying safety signals and potential extensions of use. 

  • Spinal indications

Although detail cases not formally presented, in-room polling showed several experts already using the patch in spinal settings with positive feedback, hinting at broader applicability to spinal duroplasty.


  • Endoscopic skull-base reconstruction

Many discussants considered it a good fit, where a thin, suturable, low-adhesion patch supports controlled closure in narrow, layered corridors.


  • Integration and redo surgery

Multiple remarks pointed to excellent PLLA integration. At redo, surgeons often saw regenerated coverage with no visible patch and clear dissection planes that support safe re-entry.


  • Sometimes “better than native dura” for suturing

In selected re-suturing contexts, substitutes appeared less prone to tearing than native dura—an instructive, counter-intuitive observation underscoring the importance of edge quality for long-term watertightness.


  • Infection signal

No infections were reported by participants; consensus favoured an extremely low infection rate, reinforcing usability in both routine and high-risk closures. 


4.Distilled conclusion (synthesising Part I + Part II + discussion)

This session reframed dural repair from “finding a good patch” to “building a reliable pathway.” 


  • O’Neil’s decade of UK practice showed that in large defects, high CSF gradients and revisions, balanced attributes—strength and watertightness, low adhesion with re-entry friendliness, and acceptable cost—govern durable outcomes.


  • Singleton’s paediatric lens locked in the missing piece: without CSF control, posture/gravity management and standardised suturing, even the best patch can leak.


  • Discussion added real-world momentum: expanding confidence in spine and endoscopic skull-base, strong PLLA integration with redo-friendly planes, extremely low infection, and in certain scenarios a suturing edge that rivals native dura. 


For practising surgeons, the actionable message is brief: choose one thin, truly suturable, non-swelling, low-adhesion patch that works for sutrue, inlay and onlay—then embed it in a unit pathway of CSF control and watertight suturing. Only pathways make closures predictable.